CN100537755C - 从红细胞中提取超氧化物歧化酶的方法 - Google Patents
从红细胞中提取超氧化物歧化酶的方法 Download PDFInfo
- Publication number
- CN100537755C CN100537755C CNB2007100708138A CN200710070813A CN100537755C CN 100537755 C CN100537755 C CN 100537755C CN B2007100708138 A CNB2007100708138 A CN B2007100708138A CN 200710070813 A CN200710070813 A CN 200710070813A CN 100537755 C CN100537755 C CN 100537755C
- Authority
- CN
- China
- Prior art keywords
- sod
- red corpuscle
- dismutase
- add
- concentration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 102000019197 Superoxide Dismutase Human genes 0.000 title claims abstract description 50
- 108010012715 Superoxide dismutase Proteins 0.000 title claims abstract description 50
- 229940032362 superoxide dismutase Drugs 0.000 title claims abstract description 50
- 238000000034 method Methods 0.000 title claims abstract description 26
- 239000000284 extract Substances 0.000 title claims description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims abstract description 52
- 238000001556 precipitation Methods 0.000 claims abstract description 22
- 238000007710 freezing Methods 0.000 claims abstract description 12
- 238000004587 chromatography analysis Methods 0.000 claims abstract description 11
- 210000004369 blood Anatomy 0.000 claims abstract description 10
- 239000008280 blood Substances 0.000 claims abstract description 10
- 206010018910 Haemolysis Diseases 0.000 claims abstract description 8
- 230000008588 hemolysis Effects 0.000 claims abstract description 8
- 239000012043 crude product Substances 0.000 claims abstract description 7
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 32
- 238000003756 stirring Methods 0.000 claims description 27
- 239000000872 buffer Substances 0.000 claims description 22
- 239000000243 solution Substances 0.000 claims description 20
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 16
- 239000012153 distilled water Substances 0.000 claims description 15
- 150000003839 salts Chemical class 0.000 claims description 13
- 230000007935 neutral effect Effects 0.000 claims description 12
- 239000001509 sodium citrate Substances 0.000 claims description 12
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 claims description 12
- 238000013016 damping Methods 0.000 claims description 11
- 238000010612 desalination reaction Methods 0.000 claims description 11
- 239000012530 fluid Substances 0.000 claims description 11
- 239000007788 liquid Substances 0.000 claims description 11
- 229910052751 metal Inorganic materials 0.000 claims description 11
- 239000002184 metal Substances 0.000 claims description 11
- 238000004440 column chromatography Methods 0.000 claims description 10
- 239000006228 supernatant Substances 0.000 claims description 10
- 229920005654 Sephadex Polymers 0.000 claims description 9
- 239000012507 Sephadex™ Substances 0.000 claims description 9
- DPDMMXDBJGCCQC-UHFFFAOYSA-N [Na].[Cl] Chemical compound [Na].[Cl] DPDMMXDBJGCCQC-UHFFFAOYSA-N 0.000 claims description 9
- 238000005571 anion exchange chromatography Methods 0.000 claims description 9
- 239000002808 molecular sieve Substances 0.000 claims description 9
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 claims description 9
- -1 transition metal salt Chemical class 0.000 claims description 9
- 229910052723 transition metal Inorganic materials 0.000 claims description 8
- 230000010748 Photoabsorption Effects 0.000 claims description 6
- BFSVOASYOCHEOV-UHFFFAOYSA-N 2-diethylaminoethanol Chemical compound CCN(CC)CCO BFSVOASYOCHEOV-UHFFFAOYSA-N 0.000 claims description 5
- 239000000287 crude extract Substances 0.000 claims description 5
- 210000003743 erythrocyte Anatomy 0.000 claims description 5
- 238000009413 insulation Methods 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims description 5
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 claims description 2
- 229910002651 NO3 Inorganic materials 0.000 claims description 2
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 claims description 2
- 229910052783 alkali metal Inorganic materials 0.000 claims description 2
- 150000001340 alkali metals Chemical class 0.000 claims description 2
- 150000002696 manganese Chemical class 0.000 claims description 2
- 239000002244 precipitate Substances 0.000 claims description 2
- 239000002893 slag Substances 0.000 claims description 2
- 150000003751 zinc Chemical class 0.000 claims description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 abstract description 14
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract description 6
- 238000004108 freeze drying Methods 0.000 abstract description 4
- 238000004255 ion exchange chromatography Methods 0.000 abstract description 3
- 238000004519 manufacturing process Methods 0.000 abstract description 3
- 102000004169 proteins and genes Human genes 0.000 description 7
- 108090000623 proteins and genes Proteins 0.000 description 7
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 5
- 238000000502 dialysis Methods 0.000 description 5
- 230000008014 freezing Effects 0.000 description 4
- 239000006166 lysate Substances 0.000 description 4
- 238000004321 preservation Methods 0.000 description 4
- 229920002271 DEAE-Sepharose Polymers 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 3
- 238000011033 desalting Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 239000008176 lyophilized powder Substances 0.000 description 3
- 210000002381 plasma Anatomy 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- 238000013019 agitation Methods 0.000 description 2
- ORTQZVOHEJQUHG-UHFFFAOYSA-L copper(II) chloride Chemical compound Cl[Cu]Cl ORTQZVOHEJQUHG-UHFFFAOYSA-L 0.000 description 2
- MPTQRFCYZCXJFQ-UHFFFAOYSA-L copper(II) chloride dihydrate Chemical compound O.O.[Cl-].[Cl-].[Cu+2] MPTQRFCYZCXJFQ-UHFFFAOYSA-L 0.000 description 2
- 229910000366 copper(II) sulfate Inorganic materials 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 238000005342 ion exchange Methods 0.000 description 2
- CNFDGXZLMLFIJV-UHFFFAOYSA-L manganese(II) chloride tetrahydrate Chemical compound O.O.O.O.[Cl-].[Cl-].[Mn+2] CNFDGXZLMLFIJV-UHFFFAOYSA-L 0.000 description 2
- IOLCXVTUBQKXJR-UHFFFAOYSA-M potassium bromide Chemical compound [K+].[Br-] IOLCXVTUBQKXJR-UHFFFAOYSA-M 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- WQGWDDDVZFFDIG-UHFFFAOYSA-N pyrogallol Chemical compound OC1=CC=CC(O)=C1O WQGWDDDVZFFDIG-UHFFFAOYSA-N 0.000 description 2
- JHJLBTNAGRQEKS-UHFFFAOYSA-M sodium bromide Chemical compound [Na+].[Br-] JHJLBTNAGRQEKS-UHFFFAOYSA-M 0.000 description 2
- VWDWKYIASSYTQR-UHFFFAOYSA-N sodium nitrate Chemical compound [Na+].[O-][N+]([O-])=O VWDWKYIASSYTQR-UHFFFAOYSA-N 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- 230000004304 visual acuity Effects 0.000 description 2
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 2
- 229920000936 Agarose Polymers 0.000 description 1
- 102000004506 Blood Proteins Human genes 0.000 description 1
- 108010017384 Blood Proteins Proteins 0.000 description 1
- 229910021591 Copper(I) chloride Inorganic materials 0.000 description 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 238000006701 autoxidation reaction Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 229910000365 copper sulfate Inorganic materials 0.000 description 1
- OXBLHERUFWYNTN-UHFFFAOYSA-M copper(I) chloride Chemical compound [Cu]Cl OXBLHERUFWYNTN-UHFFFAOYSA-M 0.000 description 1
- 229960003280 cupric chloride Drugs 0.000 description 1
- 229940045803 cuprous chloride Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 229960003511 macrogol Drugs 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 238000007750 plasma spraying Methods 0.000 description 1
- 229940093916 potassium phosphate Drugs 0.000 description 1
- 229910000160 potassium phosphate Inorganic materials 0.000 description 1
- 239000008057 potassium phosphate buffer Substances 0.000 description 1
- 235000011009 potassium phosphates Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 229940079877 pyrogallol Drugs 0.000 description 1
- 230000004223 radioprotective effect Effects 0.000 description 1
- 238000005185 salting out Methods 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 238000001577 simple distillation Methods 0.000 description 1
- 229940001516 sodium nitrate Drugs 0.000 description 1
- 235000010344 sodium nitrate Nutrition 0.000 description 1
- 239000004317 sodium nitrate Substances 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 229910001428 transition metal ion Inorganic materials 0.000 description 1
- 239000011592 zinc chloride Substances 0.000 description 1
- 235000005074 zinc chloride Nutrition 0.000 description 1
Landscapes
- Enzymes And Modification Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2007100708138A CN100537755C (zh) | 2007-08-17 | 2007-08-17 | 从红细胞中提取超氧化物歧化酶的方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2007100708138A CN100537755C (zh) | 2007-08-17 | 2007-08-17 | 从红细胞中提取超氧化物歧化酶的方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101139576A CN101139576A (zh) | 2008-03-12 |
CN100537755C true CN100537755C (zh) | 2009-09-09 |
Family
ID=39191680
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2007100708138A Expired - Fee Related CN100537755C (zh) | 2007-08-17 | 2007-08-17 | 从红细胞中提取超氧化物歧化酶的方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100537755C (zh) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101353370B (zh) * | 2008-09-09 | 2011-04-13 | 浙江大学 | 从禽畜血中提取血红蛋白和超氧化物歧化酶的方法 |
CN102181411A (zh) * | 2011-04-01 | 2011-09-14 | 黑龙江宝迪肉类食品有限公司 | 一种从猪血红细胞中提取超氧化物歧化酶sod的方法 |
CN102250851A (zh) * | 2011-08-10 | 2011-11-23 | 天津宝迪农业科技股份有限公司 | 从动物血球液中提取超氧化物歧化酶sod的新工艺 |
CN103397004A (zh) * | 2013-07-25 | 2013-11-20 | 天津核生科技生物工程有限公司 | 一种从高寒灵芝中提取sod的方法 |
CN103436500A (zh) * | 2013-08-22 | 2013-12-11 | 慈溪市迈康生物科技有限公司 | 一种从动物血液中提取超氧化物歧化酶的方法 |
CN104450636A (zh) * | 2014-12-29 | 2015-03-25 | 成都市真阳子生物科技有限公司 | 一种超氧化物歧化酶的制备方法 |
CN106434580A (zh) * | 2016-10-21 | 2017-02-22 | 南阳理工学院 | 一种植物超氧化物歧化酶提取的新方法 |
CN109055325B (zh) * | 2018-08-28 | 2022-08-16 | 佛山科学技术学院 | 一种鸭血红细胞sod的分离纯化方法 |
-
2007
- 2007-08-17 CN CNB2007100708138A patent/CN100537755C/zh not_active Expired - Fee Related
Non-Patent Citations (2)
Title |
---|
羊红细胞铜锌超氧化物歧化酶的纯化及部分性质研究. 张彩莹等.中国生化药物杂志,第24卷第1期. 2003 |
羊红细胞铜锌超氧化物歧化酶的纯化及部分性质研究. 张彩莹等.中国生化药物杂志,第24卷第1期. 2003 * |
Also Published As
Publication number | Publication date |
---|---|
CN101139576A (zh) | 2008-03-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100537755C (zh) | 从红细胞中提取超氧化物歧化酶的方法 | |
CN101353370B (zh) | 从禽畜血中提取血红蛋白和超氧化物歧化酶的方法 | |
CN101182495B (zh) | 以猪小肠为原料联产生产碱性磷酸酶和肝素钠的联产工艺 | |
CN102181411A (zh) | 一种从猪血红细胞中提取超氧化物歧化酶sod的方法 | |
CN103436500A (zh) | 一种从动物血液中提取超氧化物歧化酶的方法 | |
JPH0133158B2 (zh) | ||
CN110606900B (zh) | 一种具有抗氧化作用的木枣多糖的分离纯化方法 | |
CN107033237B (zh) | 一种人血浆载脂蛋白a-i的分离纯化方法 | |
EP0019477B1 (en) | Process for isolating cu, zn-superoxide dismutase from aqueous solutions, and enzyme obtained | |
NO178882B (no) | Fremgangsmåte for separasjon av vitamin K-avhengige blodkoagulerende faktorer | |
CN102628036A (zh) | 一种生产超氧化物歧化酶sod的除杂纯化新工艺 | |
JPH0151997B2 (zh) | ||
CN109438585A (zh) | 一种b型嗜血杆菌多糖的纯化工艺 | |
CN108191958B (zh) | 一种亚麻籽粕抗氧化六肽及其制备方法与应用 | |
CN102925416A (zh) | 从哺乳动物血液中提取超氧化物歧化酶的方法 | |
CN102250851A (zh) | 从动物血球液中提取超氧化物歧化酶sod的新工艺 | |
JPH05117303A (ja) | ヤマブシタケ由来の水溶性多糖類及び該水溶性多糖類を主剤とする抗腫瘍剤 | |
CN101073666B (zh) | 一种制备胰激肽原酶原料药的方法 | |
CN109055325B (zh) | 一种鸭血红细胞sod的分离纯化方法 | |
CN103397003A (zh) | 一种动物血液中超氧化物歧化酶提取技术新工艺 | |
CN1428422A (zh) | 超氧化物歧化酶大规模生产新工艺 | |
Morrison et al. | The isolation of cytochrome c by salt extraction | |
CN108822205A (zh) | 一种羊血清白蛋白的提取方法 | |
CN103665181A (zh) | 一种简易制备条斑紫菜粗多糖的方法 | |
RU2528061C1 (ru) | Способ получения цитохрома с |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: FUSHUN DANYANG BIOTECHNOLOGY CO., LTD. Free format text: FORMER OWNER: ZHEJIANG UNIVERSITY Effective date: 20130123 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 310027 HANGZHOU, ZHEJIANG PROVINCE TO: 113109 FUSHUN, LIAONING PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20130123 Address after: 113109 Fushun City, Liaoning province Dongzhou District Pan Xiang Shi Fu Cun Patentee after: Fushun Danyang biological science and Technology Co Ltd Address before: 310027 Hangzhou, Zhejiang Province, Xihu District, Zhejiang Road, No. 38, No. Patentee before: Zhejiang University |
|
C56 | Change in the name or address of the patentee | ||
CP01 | Change in the name or title of a patent holder |
Address after: 113109 Fushun City, Liaoning province Dongzhou District Pan Xiang Shi Fu Cun Patentee after: Danyang biological Polytron Technologies Inc of Fushun Address before: 113109 Fushun City, Liaoning province Dongzhou District Pan Xiang Shi Fu Cun Patentee before: Fushun Danyang biological science and Technology Co Ltd |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20090909 Termination date: 20160817 |
|
CF01 | Termination of patent right due to non-payment of annual fee |